alexa Insurance type influences the use of drug-eluting stents.
Nursing & Health Care

Nursing & Health Care

Health Economics & Outcome Research: Open Access

Author(s): Gaglia MA Jr, Torguson R, Xue Z, Gonzalez MA, Collins SD,

Abstract Share this page

Abstract OBJECTIVES: We sought to examine the effect of insurance type upon the likelihood of receiving a drug-eluting stent (DES). BACKGROUND: Recent guidelines suggest that consideration of a patient's resources should play a role in decisions to use DES. Previous studies have also documented disparities in both access to care and cardiovascular outcomes according to race, insurance, and socioeconomic status. The effect of insurance status upon the decision to use DES is unclear. METHODS: Patients undergoing percutaneous coronary intervention (PCI) with stenting from April 2003 to June 2009, the so-called DES era, were retrospectively analyzed. Multivariable logistic regression was performed separately for patients <65 years and patients > or =65 years, with receipt of > or =1 DES during PCI as the outcome variable of interest. Insurance type was categorized as private, Medicare, Medicaid, and uninsured, based upon the primary insurance at discharge. Data regarding duration of clopidogrel therapy at 1 month, 6 months, and 1 year was also collected. RESULTS: Among the 12,584 patients who underwent PCI with stenting, 6,157 (48.9\%) had private insurance, 5,689 (45.2\%) had Medicare, 467 (3.7\%) had Medicaid, and 271 (2.2\%) were uninsured at the time of hospital discharge. There were no significant differences by insurance type in duration of dual antiplatelet therapy at 1 year. Both multivariable logistic regressions showed that Medicaid patients (odds ratio [OR]: 0.60; 95\% confidence interval [CI]: 0.46 to 0.78 for age <65 years; OR: 0.45; 95\% CI: 0.24 to 0.85 for age > or =65 years) and patients without insurance (OR: 0.57; 95\% CI: 0.42 to 0.78 for age <65 years; OR: 0.20; 95\% CI: 0.05 to 0.86 for age > or =65 years) were less likely to receive DES. CONCLUSIONS: Insurance status has a significant impact upon the decision to use DES. Efforts to address this disparity should focus on the patient-provider level. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. This article was published in JACC Cardiovasc Interv and referenced in Health Economics & Outcome Research: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version